These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


777 related items for PubMed ID: 12122975

  • 1. Nonalcoholic fatty liver disease.
    Yu AS, Keeffe EB.
    Rev Gastroenterol Disord; 2002; 2(1):11-9. PubMed ID: 12122975
    [Abstract] [Full Text] [Related]

  • 2. Non-alcoholic steatohepatitis in children.
    Nanda K.
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [Abstract] [Full Text] [Related]

  • 3. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J, Lawniczak M, Marlicz W, Miezyńska-Kurtycz J, Milkiewicz P.
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [Abstract] [Full Text] [Related]

  • 4. [Nonalcoholic steatohepatitis--a "new" hepatic disease].
    Grønbaek H, Eivindson MV, Hamilton-Dutoit S, Vilstrup H.
    Ugeskr Laeger; 2003 Mar 10; 165(11):1115-8. PubMed ID: 12677985
    [Abstract] [Full Text] [Related]

  • 5. Nonalcoholic fatty liver disease.
    Hjelkrem MC, Torres DM, Harrison SA.
    Minerva Med; 2008 Dec 10; 99(6):583-93. PubMed ID: 19034256
    [Abstract] [Full Text] [Related]

  • 6. Nonalcoholic fatty liver disease (NAFLD): a comprehensive review.
    Salt WB.
    J Insur Med; 2004 Dec 10; 36(1):27-41. PubMed ID: 15104027
    [Abstract] [Full Text] [Related]

  • 7. Pediatric nonalcoholic fatty liver disease.
    Lerret SM, Skelton JA.
    Gastroenterol Nurs; 2008 Dec 10; 31(2):115-9. PubMed ID: 18391799
    [Abstract] [Full Text] [Related]

  • 8. [Nonalcoholic steatohepatitis: pathogenesis and treatment].
    Park SH.
    Korean J Hepatol; 2008 Mar 10; 14(1):12-27. PubMed ID: 18367854
    [Abstract] [Full Text] [Related]

  • 9. [NASH -- nonalcoholic steatohepatitis].
    Blechacz B, Stremmel W.
    Z Gastroenterol; 2003 Jan 10; 41(1):77-90. PubMed ID: 12541180
    [Abstract] [Full Text] [Related]

  • 10. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
    Ong JP, Elariny H, Collantes R, Younoszai A, Chandhoke V, Reines HD, Goodman Z, Younossi ZM.
    Obes Surg; 2005 Mar 10; 15(3):310-5. PubMed ID: 15826462
    [Abstract] [Full Text] [Related]

  • 11. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Younossi ZM.
    Aliment Pharmacol Ther; 2008 Jul 10; 28(1):2-12. PubMed ID: 18410557
    [Abstract] [Full Text] [Related]

  • 12. Non-alcoholic fatty liver disease and hepatitis C infection.
    Bondini S, Younossi ZM.
    Minerva Gastroenterol Dietol; 2006 Jun 10; 52(2):135-43. PubMed ID: 16557185
    [Abstract] [Full Text] [Related]

  • 13. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease.
    McCullough AJ.
    Clin Liver Dis; 2004 Aug 10; 8(3):521-33, viii. PubMed ID: 15331061
    [Abstract] [Full Text] [Related]

  • 14. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Harrison SA, Neuschwander-Tetri BA.
    Clin Liver Dis; 2004 Nov 10; 8(4):861-79, ix. PubMed ID: 15464659
    [Abstract] [Full Text] [Related]

  • 15. Nonalcoholic fatty liver disease.
    Angulo P.
    Rev Gastroenterol Mex; 2005 Nov 10; 70 Suppl 3():52-6. PubMed ID: 17471859
    [Abstract] [Full Text] [Related]

  • 16. Diabetes mellitus, obesity, and hepatic steatosis.
    Youssef W, McCullough AJ.
    Semin Gastrointest Dis; 2002 Jan 10; 13(1):17-30. PubMed ID: 11944630
    [Abstract] [Full Text] [Related]

  • 17. [Non-alcoholic fatty liver].
    Tagle Arrospide M.
    Rev Gastroenterol Peru; 2003 Jan 10; 23(1):49-57. PubMed ID: 12768215
    [Abstract] [Full Text] [Related]

  • 18. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
    Ito S, Yukawa T, Uetake S, Yamauchi M.
    Alcohol Clin Exp Res; 2007 Jan 10; 31(1 Suppl):S83-7. PubMed ID: 17331172
    [Abstract] [Full Text] [Related]

  • 19. Evaluation and management of obesity-related nonalcoholic fatty liver disease.
    Nugent C, Younossi ZM.
    Nat Clin Pract Gastroenterol Hepatol; 2007 Aug 10; 4(8):432-41. PubMed ID: 17667992
    [Abstract] [Full Text] [Related]

  • 20. The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis.
    Miele L, Forgione A, Hernandez AP, Gabrieli ML, Vero V, Di Rocco P, Greco AV, Gasbarrini G, Gasbarrini A, Grieco A.
    Eur Rev Med Pharmacol Sci; 2005 Aug 10; 9(5):273-7. PubMed ID: 16231589
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 39.